NK cells can initiate tumor cytotoxicity through specific Fc receptors expressed on their cell surface, such as CD16 (FcγRIIIA), which binds to the Fc portion of immunoglobulin (IgG) attached to the target antigen on cancer cells. The gene discussed is FCGR3A; the disease is cancer.